Home

NEW SARS-CoV-2 RT-PCR Multiplex Diagnostic Kit
Multiplex of 3 target genes and internal control in one tube for simultaneous screening. TGA approved and available for sale in Australia and overseas.
Read More
Our Research and Product Pipeline:
Diagnostics, Biotherapeutic drugs, Active Pharmaceuticals Ingredients (API); and Smart Materials & Technologies for medical applications
Innovation and Collaboration
We are devoted to scientific innovation and seeking collaboration with the world’s leading scientists and commercial partnership
Previous
Next

HA TECH is an Australian based Biotechnology company dedicated to research and development of innovative Diagnostic products, Biopharmaceuticals and Medical Technologies.

How We Can Help

Our Products

Diagnostic Kits and Reagents
Biopharmaceuticals
and APIs

Research & Development

Diagnostic Kits and Reagents
Biopharmaceuticals
and APIs

News & Events

11 Dec 2020

HA TECH SARS-CoV-2 RT-PCR Multiplex Diagnostic Kit receives TGA approval, product launched in Australia

20 Oct 2020

HA TECH received CE marking for SARS-CoV-2 RT-PCR Multiplex Diagnostic Kit
25 Aug 2020
HA TECH acquires land for large scale API manufacturing